End-point Chromogenic Method for Bacterial Endotoxin Testing: Trusted China Suppliers & Factory Solutions
Catalog Number
| Catalog No. | Description | Kit Specification and Configuration |
|---|---|---|
| ECA40TA |
BETMAT™ EC Endotoxin Assay Kit
(End-point Chromogenic Method) 40 Tests/Kit |
|
| ECA40TB |
Frequently Asked Questions (FAQ)
What is the testing principle of the BETMAT™ EC Endotoxin Assay Kit?
The BETMAT™ EC Endotoxin Assay Kit utilizes an end-point chromogenic methodology. When Gram-negative bacterial endotoxin activates the proenzyme in the Limulus Amebocyte Lysate (LAL), the activated enzyme cleaves a synthetic chromogenic substrate, releasing a yellow chromophore (pNA) that is measured spectrophotometrically at 405 nm.
What is the difference between Catalog Numbers ECA40TA and ECA40TB?
Both ECA40TA and ECA40TB feature the same core formulation and components (40 tests per kit). They typically represent different sensitivity levels, lot-specific packaging variants, or accessory configurations to align with specific European Pharmacopoeia (EP) or United States Pharmacopeia (USP) testing standards.
What components are included in each 40-test kit?
Each standard kit includes 2 vials of LAL Reagent (1.1 ml/vial), 2 vials of certified LAL Reagent Water (20 ml/vial), 2 vials of Control Standard Endotoxin (CSE), and 2 vials of Chromogenic Substrate (2.2 ml/vial).
What are the recommended storage and handling conditions?
Unreconstituted kit components should generally be stored at 2°C to 8°C in a dry environment protected from light. Reconstituted reagents should be stored according to package insert instructions, typically stored cold or frozen in single-use aliquots to avoid freeze-thaw degradation.
What instrumentation is required to read the assay results?
An absorbance microplate reader or standard spectrophotometer equipped with a 405 nm optical filter is required to measure optical density (OD) values for quantitative determination.
Can this kit be used for pharmaceutical product release testing?
Yes, the end-point chromogenic LAL method is recognized by major pharmacopeias (including USP <85>, EP 2.6.14, and JP 4.01) for in-vitro bacterial endotoxin testing of parenteral drugs, biological products, and medical devices.
